Clinical Trial Detail

NCT ID NCT03709446
Title Leflunomide in Previously Treated Metastatic Triple Negative Cancers
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Charles L Shapiro MD
Indications

triple-receptor negative breast cancer

Therapies

Leflunomide

Age Groups: adult senior

No variant requirements are available.